PP
NARI

PFS Partners’s Inari Medical, Inc. Common Stock NARI Stock Holding History

PFS Partners’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-39
Closed -$1.99K – 461
2024
Q4 		$1.99K Hold
39
– – ﹤0.01% 401
2024
Q3 		$1.61K Hold
39
– – ﹤0.01% 408
2024
Q2 		$1.88K Hold
39
– – ﹤0.01% 394
2024
Q1 		$1.87K Hold
39
– – ﹤0.01% 417
2023
Q4 		$2.53K Hold
39
– – ﹤0.01% 398
2023
Q3 		$2.55K Hold
39
– – ﹤0.01% 392
2023
Q2 		$2.27K Hold
39
– – ﹤0.01% 412
2023
Q1 		$2.41K Hold
39
– – ﹤0.01% 319
2022
Q4 		$2.48K Hold
39
– – ﹤0.01% 306
2022
Q3 		$2.83K Hold
39
– – ﹤0.01% 287
2022
Q2 		$2.65K Hold
39
– – ﹤0.01% 290
2022
Q1 		$3.54K Sell
39
-36
-48% -$2.95K ﹤0.01% 283
2021
Q4 		$6.85K Buy
+75
New +$6.43K 0.01% 239

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $426M AUM 23.62% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

PFS Partners's NARI Position: Q1 2025 in Review

PFS Partners sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 39 shares — an estimated $1.99K sold.

PFS Partners first reported a position in NARI in Q4 2021 and held it in 13 quarters. The position peaked at $6.85K in Q4 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • PFS Partners reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • PFS Partners sold 39 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $1.99K.
  • PFS Partners first reported a position in Inari Medical, Inc. Common Stock in Q4 2021 and held it in 13 quarters.
  • PFS Partners's Inari Medical, Inc. Common Stock position peaked at $6.85K in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on PFS Partners's 13F filing for Q1 2025, filed 14 Apr 2025.